The investigators hypothesize that incidence of pharyngolaryngeal postoperative pain caused by the I-gel and LMA-Suprême devices will be ≤ 5%
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
546
LMA-UNIQUE(TM) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation
LMA-SUPREME(TM) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation
I-GEL(R) single-use adult supraglottic airway device inserted during short general anesthesia under controlled ventilation
CHU Nimes
Nîmes, France
Incidence of pharyngolaryngeal postoperative pain of the three devices
Sore throat Y/N
Time frame: 24 hours
Pharyngolaryngeal postoperative pain between groups
Sore throat Y/N
Time frame: 2 hours
Time taken to place device
From first attempt at introduction until acceptable exhaled CO2 curve attained (seconds)
Time frame: End of surgery (maximum 2 hours)
Number of attempts needed to place device
Time frame: End of surgery (maximum 2 hours)
Necessity of altering the size of the device
Y/N
Time frame: End of surgery (maximum 2 hours)
Any patient movement during procedure
Y/N
Time frame: End of surgery (maximum 2 hours)
Difficulty of insertion
5-point scale: very easy-failure
Time frame: End of surgery (maximum 2 hours)
Total leakage pressure of the devices
measured directly by the respirator
Time frame: End of surgery (maximum 2 hours)
Ventilatory pressure of the devices
Time frame: End of surgery (maximum 2 hours)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Device stability during surgery
Need to change the management system airways (orotracheal intubation or others) Y/N
Time frame: End of surgery (maximum 2 hours)
Difficulty of device removal
4-point scale: very easy-very difficult
Time frame: End of surgery (maximum 2 hours)